Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Adam

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Plos One|January 17, 2019
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)Thomas Prukop, Jan Stenzel, Stephanie Wernick, et al.
European Child & Adolescent Psychiatry|June 5, 2024
Feasibility, satisfaction, and goal attainment in routine telemedicine consultation in child and adolescent psychiatry and psychotherapyManfred Döpfner, Elena von Wirth, Julia Adam, et al.
JACC. Cardiovascular Imaging|May 19, 2012
Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditisPhilipp Lurz, Ingo Eitel, Julia Adam, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
BMC Psychiatry|October 16, 2021
Progress feedback in children and adolescents with internalizing and externalizing symptoms in routine care (OPTIE study): study protocol of a randomized parallel-group trialChristopher Hautmann, Jana Rausch, Nina Geldermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
Journal of Neuroscience Research|June 27, 2020
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) ratsThomas Prukop, Stephanie Wernick, Lydie Boussicault, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Plos One|January 17, 2019
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)Thomas Prukop, Jan Stenzel, Stephanie Wernick, et al.
European Child & Adolescent Psychiatry|June 5, 2024
Feasibility, satisfaction, and goal attainment in routine telemedicine consultation in child and adolescent psychiatry and psychotherapyManfred Döpfner, Elena von Wirth, Julia Adam, et al.
JACC. Cardiovascular Imaging|May 19, 2012
Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditisPhilipp Lurz, Ingo Eitel, Julia Adam, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
BMC Psychiatry|October 16, 2021
Progress feedback in children and adolescents with internalizing and externalizing symptoms in routine care (OPTIE study): study protocol of a randomized parallel-group trialChristopher Hautmann, Jana Rausch, Nina Geldermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitorsPeter Ray, Jane Wright, Julia Adam, et al.
Journal of Neuroscience Research|June 27, 2020
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) ratsThomas Prukop, Stephanie Wernick, Lydie Boussicault, et al.
Pageof 3